Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor mirdametinib, a large multicenter study of the rare condition showed.

Researchers at Tel Aviv University have developed a new platform using polymeric nanoparticles to deliver drug pairs to ...

Lifileucel is under clinical development by Iovance Biotherapeutics and currently in Phase II for Endometrial Cancer.

Researchers at Tel Aviv University have developed a new platform using polymeric nanoparticles to deliver drug pairs to ...

In a report released yesterday, Justin Zelin from BTIG maintained a Buy rating on Verastem (VSTM – Research Report), with a price target of ...

INR:6203. how many t20 world cup england won 27% of advanced patients responded to RAF/MEK inhibitors for all cancer types in Phase 1 trial pub ...

In contrast to currently available MEK-only inhibitors, avutometinib blocks both MEK kinase activity and the ability of RAF to phosphorylate MEK. This unique mechanism allows avutometinib to block ...